Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Mitochondrial diseases are severe and largely untreatable. Owing to the many essential processes carried out by mitochondria and the complex cellular systems that support these processes, these diseases are diverse, pleiotropic, and challenging to study. Much of our current understanding of mitochondrial function and dysfunction comes from studies in the baker's yeast Saccharomyces cerevisiae. Because of its good fermenting capacity, S. cerevisiae can survive mutations that inactivate oxidative phosphorylation, has the ability to tolerate the complete loss of mitochondrial DNA (a property referred to as ‘petite-positivity’), and is amenable to mitochondrial and nuclear genome manipulation. These attributes make it an excellent model system for studying and resolving the molecular basis of numerous mitochondrial diseases. Here, we review the invaluable insights this model organism has yielded about diseases caused by mitochondrial dysfunction, which ranges from primary defects in oxidative phosphorylation to metabolic disorders, as well as dysfunctions in maintaining the genome or in the dynamics of mitochondria. Owing to the high level of functional conservation between yeast and human mitochondrial genes, several yeast species have been instrumental in revealing the molecular mechanisms of pathogenic human mitochondrial gene mutations. Importantly, such insights have pointed to potential therapeutic targets, as have genetic and chemical screens using yeast.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA
Andrews, R. M., Kubacka, I., Chinnery, P. F., Lightowlers, R. N., Turnbull, D. M., & Howell, N. (1999) · Nature Genetics · doi:10.1038/13779 · Cited by 3,337 · cited 1×
“…proteins [seven CI subunits (ND1, ND2, ND3, ND4, ND4L, ND5 and ND6), one CIII subunit (cytochrome b), three CIV subunits (COX1, COX2, COX3) and two CV subunits (ATP6, ATP8)], and 22 tRNAs and two rRNAs that are required for protein synthesis inside the organelle (Andrews et al., 1999).”
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 2×
“network and subsequent degradation by autophagy, a phenomenon called mitophagy (see Box 2) (Kim et al., 2007; Sauvanet et al., 2012; Twig et al., 2008).”
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
Narendra, D. P., Jin, S. M., Tanaka, A., Suen, D.-F., Gautier, C. A., Shen, J., Cookson, M. R., & Youle, R. J. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000298 · Cited by 2,944 · cited 2×
“…the E3 ubiquitin ligase Parkin andPTEN-inducedkinase1 (PINK1): functionalmitochondria efficiently import and degrade PINK1; when the IM potential collapses, PINK1 accumulates at the mitochondrial surface, where it recruits Parkin to initiate mitophagy (Matsuda et al., 2010; Narendra et al., 2010).”
Wallace, D. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3365 · Cited by 2,404 · cited 1×
“…are also believed to have a role in common disorders, such as diabetes, obesity, age-related neurodegenerative and cardiovascular diseases, cancer, and probably also the aging process owing to a progressive decline of mitochondrial function during life (Koopman et al., 2013; Wallace, 2012).”
Mitochondrial fusion and fission in cell life and death
Westermann, B. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3013 · Cited by 2,002 · cited 1×
“Mitochondria are organized as a network of interconnected double-membrane tubules that is continuously remodeled by fusion and fission (Chen and Chan, 2009; Westermann, 2010).”
The Role of Mitochondria in Apoptosis
Wang, C., & Youle, R. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134850 · Cited by 1,987
Matsuda, N., Sato, S., Shiba, K., Okatsu, K., Saisho, K., Gautier, C. A., Sou, Y.-S., Saiki, S., Kawajiri, S., Sato, F., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200910140 · Cited by 1,969 · cited 2×
“…the E3 ubiquitin ligase Parkin andPTEN-inducedkinase1 (PINK1): functionalmitochondria efficiently import and degrade PINK1; when the IM potential collapses, PINK1 accumulates at the mitochondrial surface, where it recruits Parkin to initiate mitophagy (Matsuda et al., 2010; Narendra et al., 2010).”
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572 · cited 1×
“…60 mutations in MNF2, which encodes a protein involved in OM fusion, have been found in individuals presenting with Charcot-Marie-Tooth disease type 2A (CMT2A), which is characterized by axonal degeneration of peripheral nerves and muscle weakness (Cartoni and Martinou, 2009; Zuchner et al., 2004).”
Selective degradation of mitochondria by mitophagy
Kim, I., Rodriguez-Enriquez, S., & Lemasters, J. J. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.034 · Cited by 1,558 · cited 2×
“network and subsequent degradation by autophagy, a phenomenon called mitophagy (see Box 2) (Kim et al., 2007; Sauvanet et al., 2012; Twig et al., 2008).”
Maternal inheritance of human mitochondrial DNA.
Giles, R. E., Blanc, H., Cann, H. M., & Wallace, D. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6715 · Cited by 1,365 · cited 2×
“…at multiple levels to regulate biogenesis, composition and turnover of the organelle in connection with cellular metabolism, signaling and stress (Harbauer et al., 2014). mtDNA maintenance and expression The human mtDNA genome is inherited through the maternal lineage (Giles et al., 1980).”
Cited by
ATP Synthase Diseases of Mitochondrial Genetic Origin
Dautant, A., Meier, T., Hahn, A., Tribouillard-Tanvier, D., di Rago, J.-P., & Kucharczyk, R. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00329 · Cited by 127
“Owing to its good fermenting capacity, yeast models of human mitochondrial diseases can be kept alive when provided with sugars like glucose even when oxidative phosphorylation is completely inactivated (Baile and Claypool, 2013; Lasserre et al., 2015).”
BackgroundMethodSelf-citationWachnowsky, C., Wesley, N. A., Fidai, I., & Cowan, J. A. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.01.021 · Cited by 25
Ganapathi, M., Friocourt, G., Gueguen, N., Friederich, M. W., Le Gac, G., Okur, V., Loaëc, N., Ludwig, T., Ka, C., Tanji, K., et al. (2022) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12526 · Cited by 18
Self-citationRNA processing and degradation mechanisms shaping the mitochondrial transcriptome of budding yeasts
Golik, P. (2024) · IUBMB Life · doi:10.1002/iub.2779 · Cited by 9
Spermidine toxicity in Saccharomyces cerevisiae due to mitochondrial complex III deficiency
Su, W.-H., Smith, J. J., Cheng, E., Nishitani, M. S., Choi, C. Y., Lee, K. R., Salzano, A. P., & Schriner, S. E. (2025) · Biogerontology · doi:10.1007/s10522-025-10233-y · Cited by 4
Metadata
- Authors
- Lasserre, J.-P., Dautant, A., Aiyar, R. S., Kucharczyk, R., Glatigny, A., Tribouillard-Tanvier, D., Rytka, J., Blondel, M., Skoczen, N., Reynier, P., Pitayu, L., Rötig, A., Delahodde, A., Steinmetz, L. M., Dujardin, G., Procaccio, V., & di Rago, J.-P.
- Venue
- Disease Models & Mechanisms
- Publisher
- The Company of Biologists
- Published
- 2015-06-01
- Volume
- 8
- Issue
- 6
- Pages
- 509-526
- ISSN
- 1754-8403 (ISSN-L)
- 1754-8411
- OpenAlex
- W2122034403
- Cited by
- 154
- References
- 32
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies. https://app.cochat.ai/papers/10.1242/dmm.020438
- The paper
- Lasserre, J.-P., Dautant, A., Aiyar, R. S., Kucharczyk, R., Glatigny, A., Tribouillard-Tanvier, D., Rytka, J., Blondel, M., Skoczen, N., Reynier, P., Pitayu, L., Rötig, A., Delahodde, A., Steinmetz, L. M., Dujardin, G., Procaccio, V., & di Rago, J.-P. (2015). Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.020438
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.